Reorganization of the Strategic Business Initiatives Unit, 44304-44306 [2023-14697]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
44304
Federal Register / Vol. 88, No. 132 / Wednesday, July 12, 2023 / Notices
I. Under Part C, Section C–B,
Organization and Functions, add the
following:
Office of Risk Management and
Internal Control (CAJE18). (1) provides
systematic, disciplined approach to
evaluate and improve the effectiveness
of risk management, internal controls,
and grant audit resolution; (2) maintains
adherence to rules with all applicable
Federal agencies on compliance
activities associated with financial
management, grants, and acquisitions
functions; (3) plans, develops, and
implements programs as appropriate to
evaluate policies, procedures, and
practices; (4) provides leadership,
direction, guidance, and coordination
on audits; (5) establishes priorities in
resolving issues while providing
exemplary customer service to our CDC
partners; and (6) develops Annual
Quality Assurance Plans.
Acquisition Branch 5 (CAJEWG). (1)
plans, directs, and conducts acquisition
of services, supplies, equipment,
research and development, studies, and
data collection for CDC through a
variety of contractual mechanisms
(competitive and non-competitive) to
support CDC’s national and
international public health operations
utilizing a wide variety of contract types
and pricing arrangements; (2) works
closely with Centers, Institute, and
Offices (CIOs) in carrying out their
public health missions; (3) provides
leadership, direction, procurement
options, and approaches in developing
specifications/statements of work and
contract awards; (4) reviews statements
of work to ensure conformity with laws,
regulations, policies, and alignment to
CDC’s public health goals; (5) negotiates
and issues contracts; (6) directs and
controls acquisition planning activities;
(7) provides continuing surveillance of
financial and administrative aspects of
acquisition-supported activities to
ensure compliance with HHS and CDC
policies; (8) coordinates and negotiates
contract modifications, reviewing and
approving contractor billings, resolving
audit findings, and performing closeout/
termination activities; (9) assures that
contractor performance is in accordance
with contractual commitments; and (10)
identifies and mitigates risks associated
with contracts and purchase orders.
Acquisition Branch 6 (CAJEWH). (1)
plans, directs, and conducts acquisition
of services, supplies, equipment,
research and development, studies, and
data collection for CDC through a
variety of contractual mechanisms
(competitive and non-competitive) to
support CDC’s national and
international public health operations
utilizing a wide variety of contract types
VerDate Sep<11>2014
17:29 Jul 11, 2023
Jkt 259001
and pricing arrangements; (2) works
closely with CIOs in carrying out their
public health missions; (3) provides
leadership, direction, procurement
options, and approaches in developing
specifications/statements of work and
contract awards; (4) reviews statements
of work to ensure conformity with laws,
regulations, policies, and alignment to
CDC’s public health goals; (5) negotiates
and issues contracts; (6) directs and
controls acquisition planning activities;
(7) provides continuing surveillance of
financial and administrative aspects of
acquisition-supported activities to
ensure compliance with HHS and CDC
policies; (8) coordinates and negotiates
contract modifications, reviewing and
approving contractor billings, resolving
audit findings, and performing closeout/
termination activities; (9) assures that
contractor performance is in accordance
with contractual commitments; and (10)
identifies and mitigates risks associated
with contracts and purchase orders.
II. Under Part C, Section C–B,
Organization and Functions, retitle the
following organizational units:
• Infectious Disease and International
Acquisition Branch to Acquisition
Branch 1 (CAJEWB)
• Chronic Disease, Preparedness,
Surveillance, and Environmental
Acquisition Branch to Acquisition
Branch 2 (CAJEWC)
• CDC-Wide, Business Services, and
Office of the Director Acquisition
Branch to Acquisition Branch 3
(CAJEWD)
• Occupational Safety and Health,
Simplified Acquisition Branch to
Acquisition Branch 4 (CAJEWE)
III. Under Part C, Section C–B,
Organization and Functions, delete the
mission or functional statements for and
replace with the following:
Office of Acquisition Services
(CAJEW). (1) provides leadership for
operations and policies relating to
agency-level acquisition functions; (2)
plans and develops CDC-wide policies,
procedures, and practices in acquisition
to support public health science and
programs; and (3) maintains a
continuing program of reviews,
evaluations, inquiries, and oversight
activities of CDC-wide acquisitions and
assistance to ensure adherence to laws,
policies, procedures, regulations, and
alignment to CDC’s public health goals.
Acquisition Branch 1 (CAJEWB). (1)
plans, directs, and conducts acquisition
of services, supplies, equipment,
research and development, studies, and
data collection for CDC through a
variety of contractual mechanisms
(competitive and non-competitive) to
support CDC’s national and
international public health operations
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
utilizing a wide variety of contract types
and pricing arrangements; (2) works
closely with CIOs in carrying out their
public health missions; (3) provides
leadership, direction, procurement
options, and approaches in developing
specifications/statements of work and
contract awards; (4) reviews statements
of work to ensure conformity with laws,
regulations, policies, and alignment to
CDC’s public health goals; (5) negotiates
and issues contracts; (6) directs and
controls acquisition planning activities;
(7) provides continuing surveillance of
financial and administrative aspects of
acquisition-supported activities to
ensure compliance with HHS and CDC
policies; (8) coordinates and negotiates
contract modifications, reviewing and
approving contractor billings, resolving
audit findings, and performing closeout/
termination activities; (9) assures that
contractor performance is in accordance
with contractual commitments; and (10)
identifies and mitigates risks associated
with contracts and purchase orders.
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2023–14694 Filed 7–11–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Reorganization of the Strategic
Business Initiatives Unit
Centers for Disease Control and
Prevention (CDC), the Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
CDC has modified its
structure. This notice announces the
reorganization of the Strategic Business
Initiatives Unit (SBI). SBI converted
from an activity within the Office of the
Director of the Office of the Chief
Operating Officer to a stand-alone
business service office known as the
Office of Strategic Business Initiatives.
DATES: This reorganization was
approved by the Director of CDC on
June 28, 2023.
SUMMARY:
E:\FR\FM\12JYN1.SGM
12JYN1
Federal Register / Vol. 88, No. 132 / Wednesday, July 12, 2023 / Notices
lotter on DSK11XQN23PROD with NOTICES1
FOR FURTHER INFORMATION CONTACT:
Kimberly Thurmond, Office of the Chief
Operating Officer, Office of the Director,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
TW–2, Atlanta, GA 30329. Telephone
770–488–4401; Email: reorgs@cdc.gov.
SUPPLEMENTARY INFORMATION: Part C
(Centers for Disease Control and
Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 88 FR 9290–9291, dated
February 13, 2023) is amended to reflect
the reorganization of the Strategic
Business Initiatives Unit within the
Office of the Chief Operating Officer,
Centers for Disease Control and
Prevention. Specifically, the changes are
as follows:
I. Under Part C, Section C–B,
Organization and Functions, after the
Office of Safety, Security and Asset
Management (CAJS) insert the
following:
• Strategic Business Initiatives (CAJT)
• Office of the Director (CAJT1)
• Management Operations Activity
(CAJT12)
• Office of Business Integrity and
Strategic Management (CAJTB)
• Office of the Federal Advisory
Committee Act Program (CAJTC)
• Office of Management Analysis
(CAJTD)
• Office of Transformation and Change
Management (CAJTE)
II. Under Part C, Section C–B,
Organization and Functions, retitle the
following organizational units:
• Strategic Business Initiatives (CAJT)
to the Office of Strategic Business
Initiatives (CAJT)
III. Under Part C, Section C–B,
Organization and Functions, add the
following functional statements:
Strategic Business Initiatives (CAJT).
(1) serves as the lead organizational
entity delivering risk management
training and support across CDC,
providing Federal Advisory Committee
Act program management, including
assessments of applicability and
guidance to all committees, boards and
other groups established by law; (2)
strengthens CDC’s administrative
guidance and change management
through agency-wide conference, gift,
policy, delegations of authority,
organization and functions, and records
management; (3) establishes a capability
to deliver transformation and change
management to the Office of the Chief
Operating Officer (OCOO), the CDC and
VerDate Sep<11>2014
17:29 Jul 11, 2023
Jkt 259001
the Agency for Toxic Substances; and
(4) serves as liaison to the HHS Office
of Inspector General (OIG) on fraud,
waste, and abuse allegations and fact
finding.
Office of the Director (CAJT1). (1)
directs, manages, coordinates and
evaluates the programs and activities of
the Office of Strategic Business
Initiatives (SBI) I; (2) develops goals and
objectives, and provides leadership,
policy formulation, and guidance in
program planning and development; (3)
provides advice and counsel to the CDC
Immediate Office of the Director (IOD),
the COO, and other senior IOD and
Centers, Institute, and Offices officials
on all SBI programs and activities; (4)
provides quality assurance and
continuous improvement by
establishing a framework for process
improvement associated with all SBI
functions; (5) conducts quality
improvement audits on all SBI program
areas of responsibility; (6) provides
project management support to SBI; (7)
develops and communicates vision/
mission, strategic plans and goals/
priorities for SBI and in alignment with
OCOO; (8) prepares special reports and
studies, as required, in collaboration
with and support of SBI; and (9) serves
as coordinator of continuity of
operations activities for SBI.
Management Operations Activity
(CAJT12). (1) provides overall
budgetary, employee relations, human
capital management, logistics and
administrative support; (2) collaborates
and maintains liaison with management
officials to monitor and address priority
issues of concern to CDC leadership; (3)
provides direction, strategy, analysis,
and operational support in all aspects of
human capital management, including
workforce and career development and
human resources operations; (4)
manages internal operational budget
processes, including planning,
execution, and monitoring; (5) manages
internal acquisition processes; (6) serves
as point of contact on all matters
concerning facilities management,
property management, equipment,
travel, and space utilization and
improvements; (7) coordinates SBI
requirements relating to contracts,
grants, cooperative agreements, and
reimbursable agreements; (8) develops
and implements administrative policies,
procedures, and operations, as
appropriate, for SBI; and (9) maintains
liaison with related CDC components
and other officials.
Office of Business Integrity and
Strategic Management (CAJTB). (1)
provides fiscal advisory services; (2)
researches and analyzes fiscal issues
and recommends solutions to address
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
44305
appropriations law matters (i.e.,
clearance for roller bags, sit-stand
workstations; food purchases, etc.); (3)
evaluates and conducts agency-wide
enterprise risk monitoring and
management training and support,
assisting programs with assessments,
building the agency risk profile, and
conducting special studies; (4) conducts
special reviews and appraises the
adequacy and effectiveness of agencywide practices and operations; (5)
coordinates responses to the OIG hotline
and other agency special reviews; (6)
serves as the representative for the CDC
Gift Review Panel; and (7) oversees the
management and implementation of the
CDC Conference Management Approval
System to ensure agency fiscal and risk
management in association with
conferences, collaborates with the Office
of Financial Resources travel office in
this endeavor.
Office of the Federal Advisory
Committee Act Program (CAJTC). (1)
provides Federal Advisory Committee
Act (FACA) program oversight and
management, including assessments of
applicability and guidance to all
committees, boards and other groups
established by law, the President, HHS
or CDC officials; (2) provides FACA and
ethics training for committee members
and CDC staff and FACA applicability
training to CDC programs and
employees; (3) manage FACA ethics
compliance, conflict of interest
mitigation, and financial disclosure
forms for special government employees
serving on FACA committees and
boards; (4) manages and supports
scheduling all advisory committees
meetings, and facilitates Federal
Register notice postings; (5) oversees
committee operations to include
nomination and charter packages,
correspondence procedures, and other
documents related to committee
members and management; and (6)
coordinates with HHS/CDC officials on
FACA-related matters to support
compliance with FACA statutory,
regulatory, and policy requirements.
Office of Management Analysis
(CAJTD). (1) consults with and provides
technical assistance to CDC programs,
HHS, and interagency partners, as
appropriate, on operational policies; (2)
develops, coordinates, and formalizes
CDC operational policies; (3) oversees
and manages the operational policy
management process, requirements, and
database; (4) oversees the records
management program; (5) serves as the
liaison to the National Archives and
Records Administration (NARA); (5)
provides training and support to all
programs on Federal records
management requirements and best
E:\FR\FM\12JYN1.SGM
12JYN1
44306
Federal Register / Vol. 88, No. 132 / Wednesday, July 12, 2023 / Notices
practices; (6) ensures compliance with
NARA and Federal records management
requirements; and (7) interprets,
analyzes, and makes recommendations
concerning delegations of program and
administrative authorities and develops
appropriate delegating documents; (8)
consults with and provides technical
assistance to CDC program officials
seeking to establish, modify, or abolish
organizational structures and functions;
(9) manages the official standard
administrative codes, coordinating with
HHS as appropriate; and (10) manages
processes, procedures, requirements,
and databases for delegations of
authority and organizational structures
and functions.
Office of Transformation and Change
Management (CAJTE). (1) develops,
enables, and promotes an OCOO
transformation framework and learning
organization; (2) develops and applies a
structured approach to change
management to promote participation
and buy-in; (3) creates and maintains an
internal collaboration site for programs
to share and build upon innovative
ideas and operational improvements; (4)
establishes continuous process
improvement ‘‘community of practice’’
to validate and share best practices
across OCOO and CDC; (5) promotes a
culture of continuous improvement
through training, consultative services,
facilitation and technical support to
build process improvement expertise
throughout OCOO; and (6) provide
support to programs in their project
work driving innovation including
facilitating faster access to and
dissemination of data and increased
effectiveness in services to support
CDC’s overall mission.
V. Under Part C, Section C–B,
Organization and Functions, the
following organizational unit is deleted
in its entirety:
Office of Strategic Business Initiatives
(CAJ13) within the Office of the
Director, Office of the Chief Operating
Officer.
lotter on DSK11XQN23PROD with NOTICES1
Delegations of Authority
All delegations and redelegations of
authority made to officials and
employees of affected organizational
components will continue in them or
their successors pending further
redelegation, provided they are
consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2023–14697 Filed 7–11–23; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
17:29 Jul 11, 2023
Jkt 259001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Reorganization of the Office of
Laboratory Science and Safety
Centers for Disease Control and
Prevention (CDC), the Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
CDC has modified its
structure. This notice announces the
reorganization of the Office of
Laboratory Science and Safety and the
establishment of the Center for
Laboratory Systems and Response.
DATES: This reorganization was
approved by the Director of CDC on
June 28, 2023.
FOR FURTHER INFORMATION CONTACT:
D’Artonya Graham, Office of the Chief
Operating Officer, Office of the Director,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
TW–2, Atlanta, GA 30329; Telephone
770–488–4401; Email: reorgs@cdc.gov.
SUPPLEMENTARY INFORMATION: Part C
(Centers for Disease Control and
Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 88 FR 9290–9291, dated
February 13, 2023) is amended to reflect
the reorganization of the Office of
Laboratory Science and Safety.
Immediate Office of the Director,
Centers for Disease Control and
Prevention. Specifically, the changes are
as follows:
I. Under Part C, Section C–B,
Organization and Functions, insert the
following:
• Office of the Laboratory Science and
Safety (CAN)
• Office of the Director (CAN1)
• Office of Infectious Diseases
Laboratory Quality (CAN12)
• Office of Laboratory Safety (CAN13)
• Office of Laboratory Science (CAN14)
• Center for Laboratory Systems and
Response (CANB)
• Division of Laboratory Systems
(CANBB)
• Office of the Director (CANBB1)
• National Laboratory Response
Systems Branch (CANBBB)
• Quality and Safety Systems Branch
(CANBBC)
• Training and Workforce Development
Branch (CANBBD)
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
II. Under Part C, Section C–B,
Organization and Functions, delete the
mission or functional statements for and
replace with the following:
Office of Laboratory Science and
Safety (CAN). In carrying out its
mission, the Office of Laboratory
Science and Safety: (1) provides
scientific, technical, and managerial
expertise and leadership in the
development and enhancement of
laboratory safety programs; (2) oversees
and monitors the development,
implementation, and evaluation of the
laboratory safety and quality
management programs across CDC; (3)
oversees the development and
distribution of guidance and
interpretation of Clinical Laboratory
Improvement Amendments (CLIA)
regulations for infectious disease
laboratories and monitors and ensures
laboratory compliance; and (4) bridges
and strengthens the Nation’s clinical
and public health laboratory system by
continually improving quality and
safety, informatics and data science, and
workforce competency.
Office of the Director (CAN1). (1)
provides scientific, technical, and
managerial expertise and leadership in
the development and enhancement of
laboratory science and safety programs;
(2) oversees and monitors the
development, implementation, and
evaluation of the laboratory safety and
quality management programs across
CDC; (3) provides the understanding of
CLIA regulations and tools needed by
the infectious diseases laboratories to
operate in compliance with established
requirements; (4) advises on policy,
partnerships, and issues management
matters; (5) advises on matters related to
internal and external public health
communications; (6) provides oversight
to ensure CDC compliance with
regulations for select agents and toxins,
and the safe possession, use, and
transfer of select agents and toxins; (7)
provides oversight to ensure CDC
compliance with all applicable laws,
regulations, policies, and standards
regarding the humane care and use of
laboratory animals at CDC; (8) serves as
the Institutional Official for purposes of
compliance with the Public Health
Service Policy on Humane Care and Use
of Laboratory Animals; (9) makes
appointments to the CDC Institutional
Animal Care and Use Committees; (10)
leads responses to laboratory incidents
and emergencies; (11) guides the
development of laboratory systems
standards for quality and safety; and
(12) bridges and strengthens the
Nation’s clinical and public health
laboratory system by continually
improving quality and safety,
E:\FR\FM\12JYN1.SGM
12JYN1
]]>Agencies
[Federal Register Volume 88, Number 132 (Wednesday, July 12, 2023)]
[Notices]
[Pages 44304-44306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-14697]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Reorganization of the Strategic Business Initiatives Unit
AGENCY: Centers for Disease Control and Prevention (CDC), the
Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: CDC has modified its structure. This notice announces the
reorganization of the Strategic Business Initiatives Unit (SBI). SBI
converted from an activity within the Office of the Director of the
Office of the Chief Operating Officer to a stand-alone business service
office known as the Office of Strategic Business Initiatives.
DATES: This reorganization was approved by the Director of CDC on June
28, 2023.
[[Page 44305]]
FOR FURTHER INFORMATION CONTACT: Kimberly Thurmond, Office of the Chief
Operating Officer, Office of the Director, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, MS TW-2, Atlanta, GA 30329.
Telephone 770-488-4401; Email: [email protected].
SUPPLEMENTARY INFORMATION: Part C (Centers for Disease Control and
Prevention) of the Statement of Organization, Functions, and
Delegations of Authority of the Department of Health and Human Services
(45 FR 67772-76, dated October 14, 1980, and corrected at 45 FR 69296,
October 20, 1980, as amended most recently at 88 FR 9290-9291, dated
February 13, 2023) is amended to reflect the reorganization of the
Strategic Business Initiatives Unit within the Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
Specifically, the changes are as follows:
I. Under Part C, Section C-B, Organization and Functions, after the
Office of Safety, Security and Asset Management (CAJS) insert the
following:
Strategic Business Initiatives (CAJT)
Office of the Director (CAJT1)
Management Operations Activity (CAJT12)
Office of Business Integrity and Strategic Management (CAJTB)
Office of the Federal Advisory Committee Act Program (CAJTC)
Office of Management Analysis (CAJTD)
Office of Transformation and Change Management (CAJTE)
II. Under Part C, Section C-B, Organization and Functions, retitle
the following organizational units:
Strategic Business Initiatives (CAJT) to the Office of
Strategic Business Initiatives (CAJT)
III. Under Part C, Section C-B, Organization and Functions, add the
following functional statements:
Strategic Business Initiatives (CAJT). (1) serves as the lead
organizational entity delivering risk management training and support
across CDC, providing Federal Advisory Committee Act program
management, including assessments of applicability and guidance to all
committees, boards and other groups established by law; (2) strengthens
CDC's administrative guidance and change management through agency-wide
conference, gift, policy, delegations of authority, organization and
functions, and records management; (3) establishes a capability to
deliver transformation and change management to the Office of the Chief
Operating Officer (OCOO), the CDC and the Agency for Toxic Substances;
and (4) serves as liaison to the HHS Office of Inspector General (OIG)
on fraud, waste, and abuse allegations and fact finding.
Office of the Director (CAJT1). (1) directs, manages, coordinates
and evaluates the programs and activities of the Office of Strategic
Business Initiatives (SBI) I; (2) develops goals and objectives, and
provides leadership, policy formulation, and guidance in program
planning and development; (3) provides advice and counsel to the CDC
Immediate Office of the Director (IOD), the COO, and other senior IOD
and Centers, Institute, and Offices officials on all SBI programs and
activities; (4) provides quality assurance and continuous improvement
by establishing a framework for process improvement associated with all
SBI functions; (5) conducts quality improvement audits on all SBI
program areas of responsibility; (6) provides project management
support to SBI; (7) develops and communicates vision/mission, strategic
plans and goals/priorities for SBI and in alignment with OCOO; (8)
prepares special reports and studies, as required, in collaboration
with and support of SBI; and (9) serves as coordinator of continuity of
operations activities for SBI.
Management Operations Activity (CAJT12). (1) provides overall
budgetary, employee relations, human capital management, logistics and
administrative support; (2) collaborates and maintains liaison with
management officials to monitor and address priority issues of concern
to CDC leadership; (3) provides direction, strategy, analysis, and
operational support in all aspects of human capital management,
including workforce and career development and human resources
operations; (4) manages internal operational budget processes,
including planning, execution, and monitoring; (5) manages internal
acquisition processes; (6) serves as point of contact on all matters
concerning facilities management, property management, equipment,
travel, and space utilization and improvements; (7) coordinates SBI
requirements relating to contracts, grants, cooperative agreements, and
reimbursable agreements; (8) develops and implements administrative
policies, procedures, and operations, as appropriate, for SBI; and (9)
maintains liaison with related CDC components and other officials.
Office of Business Integrity and Strategic Management (CAJTB). (1)
provides fiscal advisory services; (2) researches and analyzes fiscal
issues and recommends solutions to address appropriations law matters
(i.e., clearance for roller bags, sit-stand workstations; food
purchases, etc.); (3) evaluates and conducts agency-wide enterprise
risk monitoring and management training and support, assisting programs
with assessments, building the agency risk profile, and conducting
special studies; (4) conducts special reviews and appraises the
adequacy and effectiveness of agency-wide practices and operations; (5)
coordinates responses to the OIG hotline and other agency special
reviews; (6) serves as the representative for the CDC Gift Review
Panel; and (7) oversees the management and implementation of the CDC
Conference Management Approval System to ensure agency fiscal and risk
management in association with conferences, collaborates with the
Office of Financial Resources travel office in this endeavor.
Office of the Federal Advisory Committee Act Program (CAJTC). (1)
provides Federal Advisory Committee Act (FACA) program oversight and
management, including assessments of applicability and guidance to all
committees, boards and other groups established by law, the President,
HHS or CDC officials; (2) provides FACA and ethics training for
committee members and CDC staff and FACA applicability training to CDC
programs and employees; (3) manage FACA ethics compliance, conflict of
interest mitigation, and financial disclosure forms for special
government employees serving on FACA committees and boards; (4) manages
and supports scheduling all advisory committees meetings, and
facilitates Federal Register notice postings; (5) oversees committee
operations to include nomination and charter packages, correspondence
procedures, and other documents related to committee members and
management; and (6) coordinates with HHS/CDC officials on FACA-related
matters to support compliance with FACA statutory, regulatory, and
policy requirements.
Office of Management Analysis (CAJTD). (1) consults with and
provides technical assistance to CDC programs, HHS, and interagency
partners, as appropriate, on operational policies; (2) develops,
coordinates, and formalizes CDC operational policies; (3) oversees and
manages the operational policy management process, requirements, and
database; (4) oversees the records management program; (5) serves as
the liaison to the National Archives and Records Administration (NARA);
(5) provides training and support to all programs on Federal records
management requirements and best
[[Page 44306]]
practices; (6) ensures compliance with NARA and Federal records
management requirements; and (7) interprets, analyzes, and makes
recommendations concerning delegations of program and administrative
authorities and develops appropriate delegating documents; (8) consults
with and provides technical assistance to CDC program officials seeking
to establish, modify, or abolish organizational structures and
functions; (9) manages the official standard administrative codes,
coordinating with HHS as appropriate; and (10) manages processes,
procedures, requirements, and databases for delegations of authority
and organizational structures and functions.
Office of Transformation and Change Management (CAJTE). (1)
develops, enables, and promotes an OCOO transformation framework and
learning organization; (2) develops and applies a structured approach
to change management to promote participation and buy-in; (3) creates
and maintains an internal collaboration site for programs to share and
build upon innovative ideas and operational improvements; (4)
establishes continuous process improvement ``community of practice'' to
validate and share best practices across OCOO and CDC; (5) promotes a
culture of continuous improvement through training, consultative
services, facilitation and technical support to build process
improvement expertise throughout OCOO; and (6) provide support to
programs in their project work driving innovation including
facilitating faster access to and dissemination of data and increased
effectiveness in services to support CDC's overall mission.
V. Under Part C, Section C-B, Organization and Functions, the
following organizational unit is deleted in its entirety:
Office of Strategic Business Initiatives (CAJ13) within the Office
of the Director, Office of the Chief Operating Officer.
Delegations of Authority
All delegations and redelegations of authority made to officials
and employees of affected organizational components will continue in
them or their successors pending further redelegation, provided they
are consistent with this reorganization.
(Authority: 44 U.S.C. 3101)
Robin D. Bailey, Jr.,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-14697 Filed 7-11-23; 8:45 am]
BILLING CODE 4163-18-P
